Eastman Kodak

Eastman Kodak Co. engages in the provision of analog and digital innovations. It operates through the following segments: Traditional Printing, Digital Printing, Advanced Materials and Chemicals, and Brand. The Traditional Printing segment consists of Prepress Solutions, which includes Kodak's digital offset plate offerings and computer-to-plate imaging solutions. The Digital Printing segment contains Electrophotographic Printing Solutions, Prosper, Versamark and Software. The Advanced Materials and Chemicals segment consists of four lines of business: Industrial Film and Chemicals, Motion Picture, Advanced Materials and Functional Printing, and Kodak Services for Business (KSB). The Brand segment includes licensing of the Kodak brand to third parties. The company was founded by George Eastman in 1880 and is headquartered in Rochester, NY.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Kodak reports mixed Q4 results, focuses on innovation for growth

Kodak showcased a resilient performance in Q4 and full year 2022, marked by revenue growth and gross profit improvements. The company's focus on innovation and strategic investments bodes well for future prospects.
While facing challenges such as revenue fluctuations and currency impacts, Kodak's compliance with financial covenants and emphasis on cost controls position it for sustained profitability and growth.

Eastman Kodak reports Q1 growth in revenues and profit

Eastman Kodak's Q1 2023 performance showed revenue decline adjusted for foreign exchange but a significant increase in gross profit and net income. The company's focus on core businesses, smart revenues, and efficiency improvements positions it for sustainable growth despite market challenges.

Eastman Kodak reports Q2 revenue decline but boosts profitability

Eastman Kodak's Q2 2023 performance showed mixed results with revenue decline but improved profitability and net income.
The company's strategic strengths include investments in innovation, key acquisitions, and prudent financial management.
Challenges persist in revenue decline and global uncertainties, but opportunities exist in leveraging innovation and strategic partnerships for growth.

Eastman Kodak reports improved Q3 performance amidst challenges

Eastman Kodak's Q3 2023 performance showed resilience amidst challenges, with improved financial metrics and a focus on long-term strategy execution. The company's commitment to innovation, growth initiatives, and customer support positions it well for future opportunities.

Eastman Kodak reports mixed Q4 results, focuses on growth initiatives

Eastman Kodak's Q4 2023 performance showed improvements in gross profit and operational EBITDA, despite a revenue decrease. The company's strategic investments in growth areas and commitment to innovation are key strengths.
Challenges include revenue decline and net income decrease, highlighting the need for operational efficiency enhancements. Opportunities lie in leveraging investments for revenue growth and exploring new market segments for expansion.
With a focus on profitability, cash flow generation, and strategic initiatives, Eastman Kodak aims to navigate challenges and capitalize on growth opportunities for sustainable success in the future.

Eastman Kodak reports Q1 resilience with focus on innovation

Eastman Kodak's Q1 2024 performance showed resilience in managing revenue decline while improving operational efficiency and profitability. The company's strategic investments in innovation, print technology, and automation position it for long-term growth. Challenges persist in revenue generation, but Kodak's commitment to innovation and profitability drives its pursuit of opportunities in chemicals, manufacturing, and customer-centric solutions.

Eastman Kodak reports Q3 revenue decline but boosts net income

Eastman Kodak's Q3 2024 performance saw a slight decline in revenues but an increase in net income.
The company faces challenges with lower gross profit and operational EBITDA impacted by costs.
However, Kodak's strengths lie in its focus on innovation, favorable tariffs ruling, and commitment to growth.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

The head of the U.S. House Financial Services Committee and other top Democratic lawmakers on Wednesday asked federal regulators to investigate securities transactions made by Eastman Kodak and its executives around the time it learned it could receive a $765 million government loan.

House Democrats urge SEC to dig into Kodak transactions

NEW YORK--(BUSINESS WIRE)-- #EastmamKodakCompany--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Eastman Kodak Company (NYSE: KODK) on behalf of long-term stockholders who have held since prior to July 27, 2020.

KODAK LONG-TERM INVESTOR ALERT: Bragar Eagel & Squire, P.C. is Investigating Eastman Kodak Company on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm

The U.S. House Financial Services Committee on Wednesday asked federal regulators to investigate securities transactions made by Eastman Kodak and its executives around the time it learned it could receive a $765 million government loan.

U.S. House committee urges SEC to dig into Kodak transactions

BERWYN, Pa., Aug. 5, 2020 /PRNewswire/ -- RM LAW, P.C.

RM LAW Announces Investigation of Eastman Kodak Company

Strong trading before the official announcement of a $765 million loan spurred the Securities and Exchange Commission to investigate.

Kodak Stock's Unusual Activity Prompts SEC Investigation

Democratic lawmakers who chair key House committees on Wednesday said they're investigating how Eastman Kodak Co.

Top House Democrats announce probe into Kodak's $765 million government loan

The Securities and Exchange Commission is reportedly investigating how Eastman Kodak received a a $765 million loan from the US government to help make drug ingredients, according to the Wall Street Journal.

Kodak is reportedly under SEC investigation after its stock price exploded more than 2,757%

LOS ANGELES--(BUSINESS WIRE)---- $KODK #KODK--ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eastman Kodak Company

ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eastman Kodak Company and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

A surprising pivot made the struggling photography company one of the hottest stocks on the market.

Why Kodak Stock Skyrocketed 879.8% in July

After Eastman Kodak received a $765 million loan from the government to produce drug ingredients, the SEC is reportedly investigating.
 After Eastman Kodak received a $765 million loan from the government to produce drug ingredients, the Securities and Exchange Commission is reportedly investigating some of the details.

Report: The SEC is investigating details around Eastman Kodak’s government loan

Kodak stock rallies at 1500% after the company receives a $765 loan from the government to produce the drugs required to combat Covid-19. 
The post Kodak’s New Business Model Is a Frame-able Moment appeared first on InvestorPlace.

Kodak’s New Business Model Is a Frame-able Moment

The film and digital imaging specialist has turned a new leaf, but can it succeed?

3 Things Eastman Kodak Stock Bulls Need to Happen Soon

Eastman Kodak Company (NYSE: KODK) is under investigation by the United States Securities and Exchange Commission surrounding the announcement of a $765 million federal loan for its foray into pharmaceuticals last month, the Wall Street Journal reported Tuesday.

Kodak's $765M Federal Loan Disclosure For Drug Venture Under SEC Investigation: WSJ

NEW YORK, Aug. 4, 2020 /PRNewswire/ -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of Eastman Kodak Co.

Investor Alert: Kaplan Fox Investigates Potential Insider Trading And Securities Fraud At Eastman Kodak Co.

Reports of an SEC investigation have investors on edge.

Why Kodak Stock Fell Today

SAN DIEGO, Aug. 4, 2020 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against Eastman Kodak Company ("Kodak" or "the Company") (NYSE:KODK) for violations of federal securities laws.

KODK Alert: Johnson Fistel Launches Investigation into Eastman Kodak Following SEC Inquiry; Investors Suffering Losses Encouraged to Contact Firm

Los Angeles, California--(Newsfile Corp. - August 4, 2020) -  The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Eastman Kodak Company ("Kodak" or "the Company") (NYSE: KODK) for potential breaches of fiduciary duty on the part of its directors and management.If you are a shareholder, click here to participate.We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century.

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Eastman Kodak Company and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES--(BUSINESS WIRE)---- $KODK #KODK--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eastman Kodak Company.

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Eastman Kodak Company and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

The day before the deal was announced, trading volume was seven times the average daily volume the previous 30 trading days.

SEC Reportedly Probing Kodak For Stock Trades Before Blockbuster Pharmaceutical Deal

The Securities and Exchange Commission is probing Kodak’s handling of material information about the startup pharmaceutical business it’s launching with the help of Uncle Sam.  According to the Wall Street Journal, the regulator is examining whether Kodak jumped the gun on a July 28 announcement that it had received a $765 million federal loan to.

SEC probes Kodak’s handling of pharmaceutical business: report

NEW YORK--(BUSINESS WIRE)-- #EastmanKodakCompany--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Eastman Kodak Company (NYSE: KODK) on behalf of Kodak stockholders.

KODAK ALERT: Bragar Eagel & Squire, P.C. is Investigating Eastman Kodak Company on Behalf of Stockholders and Encourages Investors to Contact the Firm

Kodak’s stock went up substantially, shocking everyone. Does this mean the company is back in business?

Why the Kodak Stock Skyrocketed

The U.S. Securities and Exchange Commission is investigating the circumstances around Eastman Kodak Co's announcement of a $765 million government loan to make drugs at its U.S. factories, the Wall Street Journal reported on Tuesday.

SEC investigates Kodak's U.S. government loan disclosure: WSJ

The SEC's probe, which is still at an early stage, is focused on how Kodak disclosed the deal with the government, the Journal reported, citing people familiar with the matter.

Kodak reportedly under SEC investigation over disclosure of U.S. drug producing deal

Kodak is back in the news again after some time flying under the radar, and for a somewhat surprising reason: The Trump administration has tapped the legacy film and photography pioneer to produce pharmaceutical ingredients.

News for Eastman Kodak Stock (KODK)